USA flag logo/image

An Official Website of the United States Government

New Tracking Approach for 3D Vascular Ultrasound

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
66121
Program Year/Program:
2003 / SBIR
Agency Tracking Number:
EB000581
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ASCENSION TECHNOLOGY CORPORATION
107 CATAMOUNT DRIVE MILTON, VT 05468
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2003
Title: New Tracking Approach for 3D Vascular Ultrasound
Agency: HHS
Contract: 1R43EB000581-01A1
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION (provided by applicant): Ultrasound is widely used for imaging of blood vessels because it is non-invasive, real-time, and relatively inexpensive. Reliable quantitative evaluation of blood vessels plays a pivotal role in cardiovascular disease diagnosis and follow-up intervention to avoid progression to life or limb-threatening stages. These studies require accurate vessel measurement for size analysis and registration between serial studies for monitoring disease progression before and/or after vascular repair. Sites of particular interest are (1.) carotid arteries for risk of stroke, (2.) lower-limb bypass grafts for risk of limb loss, and (3.) abdominal aortic aneurysms for risk of rupture. Newly developed endo-vascular treatments further demand highly accurate 3D reconstructions of vessels for follow-up to assure success of the procedure or to evaluate the efficacy of the devices. A major constraint to 3D vascular imaging is the imprecision and mechanical restrictions of positioning tools. Magnetic tracking overcomes line-of-sight and mechanical restrictions, but has range limitations and distortion caused by nearby metal. Optical technology is precise but suffers from occlusion, high cost, and bulkiness. For clinical acceptability, a new approach is needed to overcome limitations while allowing precise measurment of vascular structures and/or changes. The Phase I goal will prove the feasibility of a new, hybrid (magnetic-optical) tracking technology for use in 3D vascular imaging. Accuracy of 0.5 mm/0.5 degree is the first design goal. Phase II product goals will be: (1.) Accurate (0.1mm/0.07degree) measurement of a sensor attached to an ultrasound scanhead, (2.) freedom to track the scanhead the length of an adult limb of a patient lying on a standard medical procedural table, (3.) no data impairment due to metallic distortion or noise interference. Full development will enable clinicians to quantitatively analyze 3D reconstructions as a precise means of assessing morphological changes over time, compared to current 2D slice-by-slice delineation and interpretation of vessel boundaries. The new technology will also further the development of new imageguided techniques for use in minimally-invasive procedures.

Principal Investigator:

Westley S. Ashe
8028936657
WASHE@ASCENSION-TECH.COM

Business Contact:

Jack Scully
8028936657
JSCULLY@ASCENSION-TECH.COM
Small Business Information at Submission:

ASCENSION TECHNOLOGY CORPORATION
107 CATAMOUNT DRIVE MILTON, VT 05468

EIN/Tax ID: 030301316
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No